Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial.

Stefan KnopMaria-Victoria MateosMeletios A DimopoulosKenshi SuzukiAndrzej JakubowiakChantal DoyenPaulo LucioZsolt NagyGanna UsenkoLudek PourMark CookSebastian GrosickiAndre CrepaldiAnna Marina LiberatiPhilip CampbellTatiana ShelekhovaSung-Soo YoonGenadi LosavaTomoaki FujisakiMamta GargJianping WangSusan WroblewskiAnupa KudvaKatharine S GriesJohn FastenauJesus San-MiguelMichele Cavo

Published in: BMC cancer (2021)

ClinicalTrials.gov identifier NCT02195479 , registered September 21, 2014.

Keyphrases

phase iii
stem cell transplantation
newly diagnosed
multiple myeloma
open label
high dose
double blind
clinical trial
placebo controlled
phase ii
study protocol
low dose